Epi proColon
Epi proColon®
 
Epi proColon
Product features:
  • First molecular DNA blood test for colorectal cancer screening
  • Detects methylated Septin 9 in plasma
  • FDA approved for patients that have refused FIT testing or colonoscopy
  • Minimally-invasive blood test

What you need to know about Epi proColon

Colorectal Cancer Screening

 

On April 13, 2016, the FDA announced the approval of Epi proColon. It is the first and only blood-based colorectal cancer screening test. This test will possibly increase the participation rates in colorectal cancer screening by providing another option to get screened for colorectal cancer. Epi proColon has the potential to become an asset for many laboratories all over the country to join the fight on colorectal cancer.

How does the test work?

The test will detect a marker in the blood plasma (Septin9) which is specific to colorectal cancer. A simple blood sample taken by a routine health care provider is sufficient for the test. The sample is analyzed at a diagnostic laboratory and the results are ready in a week’s time.

Who is this test for?

The Epi proColon test is used for average risk colorectal cancer screening for people age 50 and older. It is also used for people who are unable to be screened by colonoscopy.

What is Colorectal Cancer?

Colorectal cancer is the third most common type of cancer in men and women in the United States. It is cancer that starts in the colon or rectum. While digestion takes place, food moves through the stomach and small intestine into the colon. The job of the colon is to absorb water and nutrients from the food and storethe waste matter (feces). The feces then proceeds to the rectum from the colon before it leaves the body.

Most colorectal cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Colorectal cancer often begins as a growth called a polyp, which can form on the inner wall of the rectum or colon. Over time they become cancerous. Removing these polyps can prevent colorectal cancer.

Do I need to restrict my diet before taking this test?

Blood samples for the test can be taken anytime. There are no nutritional requirements or other preparations that need to be made before conducting the test.

What is the detection rate of colorectal cancer?

When tested in 32 different clinical sites, the Epi proColon blood test was positive for seven out of 10 colorectal cancers when colorectal cancer was present. It tested positive two out of 10 times when colorectal cancer was not present. The test was conducted on average risk patients in the age group of 50-85.

If my Epi proColon test is positive, do I still need to get a colonoscopy done?

Yes. A Colonoscopy examines the interior lining of the intestine and rectum. The Epi proColon test can detect colorectal cancer, but your physician will schedule a colonoscopy to confirm the results.

Call Us if You Want a Screening Done

Polymedco CDP, LLC is the leading manufacturer, marketer, and distributor of clinical diagnostic test kits. We are the world leaders in non-invasive colorectal cancer screening technology. If you need a screening done for colorectal cancer, you can contact us at 888-638-7757 or e-mail at info@polymedco.com.


Other Products:
facebook
facebook